AL Kritski, MJ Marques, MF Rabahi, MA Vieira, E Werneck-Barroso, CE Carvalho, N Andrade G de, R Bravo-de-Souza, LM Andrade, PP Gontijo and LW Riley
Servico de Pneumologia, Hospital Clementino Fraga Filho, Universidade Federal de Rio de Janeiro, Brazil.

Multidrug-resistant tuberculosis (MDRTB) has emerged as a major public health problem worldwide. To determine the incidence and risk factors associated with tuberculosis among contacts of MDRTB index cases, we studied human immunodeficiency virus-seronegative close contacts of 64 culture-confirmed MDRTB patients in Rio de Janeiro, Brazil. Between March 1988 and July 1992, tuberculosis developed in 17 (7.8%) of 218 previously healthy close contacts of 64 MDRTB index cases (1.6 cases per 1,000-person-months of contact). Among strains of Mycobacterium tuberculosis isolated from 13 contacts of 12 index cases, six (46%) had susceptibility patterns identical to those of their index cases, four (31%) had different patterns of resistance, and three (23%) were susceptible to all drugs. Tuberculosis developed more frequently in male contacts (p < 0.05), persons > or = 15 yr of age (p < 0.05), nonwhites (p < 0.001), and persons not previously vaccinated with bacillus Calmette-Guerin (BCG) (p < 0.05). The association of BCG vaccination with decreased risk of disease was significant even when this variable was controlled (by Cox's regression analysis) for age, sex, race, purified protein derivative (PPD) status, and isoniazid prophylaxis. BCG vaccination appears to offer protection against tuberculosis during prolonged exposures to persons with MDRTB, which identifies a novel and specific indication of BCG use.

This article has been cited by other articles:

				S. KESHAVJEE, I.Y. GELMANOVA, A.D. PASECHNIKOV, S.P. MISHUSTIN, Y.G. ANDREEV, A. YEDILBAYEV, J.J. FURIN, J.S. MUKHERJEE, M.L. RICH, E.A. NARDELL, et al. Treating Multidrug-Resistant Tuberculosis in Tomsk, Russia: Developing Programs That Address the Linkage between Poverty and Disease Ann. N.Y. Acad. Sci., June 1, 2008; 1136(1): 1 - 11. [Abstract] [Full Text] [PDF]

				M. Schechter, R. Zajdenverg, G. Falco, G. L. Barnes, J. C. Faulhaber, J. S. Coberly, R. D. Moore, and R. E. Chaisson Weekly Rifapentine/Isoniazid or Daily Rifampin/Pyrazinamide for Latent Tuberculosis in Household Contacts Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 922 - 926. [Abstract] [Full Text] [PDF]

				D. A. J. Moore, D. Mendoza, R. H Gilman, C. A. W. Evans, M.-G. Hollm Delgado, J. Guerra, L. Caviedes, D. Vargas, E. Ticona, J. Ortiz, et al. Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings J. Clin. Microbiol., October 1, 2004; 42(10): 4432 - 4437. [Abstract] [Full Text] [PDF]

				H. R. van Doorn, E. C. J. Claas, K. E. Templeton, A. G. M. van der Zanden, A. te Koppele Vije, M. D. de Jong, J. Dankert, and E. J. Kuijper Detection of a Point Mutation Associated with High-Level Isoniazid Resistance in Mycobacterium tuberculosis by Using Real-Time PCR Technology with 3'-Minor Groove Binder-DNA Probes J. Clin. Microbiol., October 1, 2003; 41(10): 4630 - 4635. [Abstract] [Full Text] [PDF]

				A. C. C. CARVALHO, K. DERIEMER, Z. B. NUNES, M. MARTINS, M. COMELLI, A. MARINONI, and A. L. KRITSKI Transmission of Mycobacterium tuberculosis to Contacts of HIV-infected Tuberculosis Patients Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2166 - 2171. [Abstract] [Full Text] [PDF]

				P. FARMER DOTS and DOTS-Plus: Not the Only Answer Ann. N.Y. Acad. Sci., December 1, 2001; 953(1): 165 - 184. [Abstract] [Full Text] [PDF]

				H. R. van Doorn, E. J. Kuijper, A. van der Ende, A. G. A. Welten, D. van Soolingen, P. E. W. de Haas, and J. Dankert The Susceptibility of Mycobacterium tuberculosis to Isoniazid and the Arg{right-arrow}Leu Mutation at Codon 463 of katG Are Not Associated J. Clin. Microbiol., April 1, 2001; 39(4): 1591 - 1594. [Abstract] [Full Text]

				M. P. Arbelaez, K. E Nelson, and A. Munoz BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection Int. J. Epidemiol., December 1, 2000; 29(6): 1085 - 1091. [Abstract] [Full Text] [PDF]

				P. Farmer and J. Y. Kim Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus" BMJ, September 5, 1998; 317(7159): 671 - 674. [Full Text]

				Y. Suzuki, C. Katsukawa, A. Tamaru, C. Abe, M. Makino, Y. Mizuguchi, and H. Taniguchi Detection of Kanamycin-Resistant Mycobacterium tuberculosis by Identifying Mutations in the 16S rRNA Gene J. Clin. Microbiol., May 1, 1998; 36(5): 1220 - 1225. [Abstract] [Full Text]